Application Note

LVV Characterization Using The QuantStudio Absolute Q Digital PCR System

GettyImages-1259094551 Digital quality

This study focuses on the characterization of recombinant lentiviral vectors used in gene-modified cell therapies, utilizing two real-time PCR assays adapted to the Applied Biosystems™ QuantStudio™ Absolute Q™ Digital PCR System. The Applied Biosystems™ ViralSEQ™ Lentivirus Physical Titer Kit quantifies the total number of genome-containing lentiviral particles, while the Applied Biosystems™ ViralSEQ™ Lentivirus Proviral DNA Titer Kit measures vector integration in transduced cells. The QuantStudio Absolute Q Digital PCR System simplifies the digital PCR process, enhancing usability and consistency. The ViralSEQ Lentivirus Titer Kits provide robust assays for the characterization of lentiviral vectors, facilitating seamless quantitation and correlation of total and infectious titers. Used in conjunction with the QuantStudio Absolute Q Digital PCR System, these kits allow for regulatory compliance without the need for additional time and resources.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Thermo Fisher Scientific Bioproduction